Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?

Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis

(2014) G. Murugaiyan et al.   JOURNAL OF IMMUNOLOGY

Decreased interferon-α production in response to CpG DNA dysregulates cytokine responses in patients with multiple sclerosis

(2012) Makoto Hirotani et al.   CLINICAL IMMUNOLOGY

Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients

(2012) Dàlia Raϊch-Regué et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis

(2012) Clara de Andrés et al.   PLoS One

Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis

(2011) Thommey P. Thomas et al.   ARTHRITIS AND RHEUMATISM

Glatiramer Acetate in the Treatment of Multiple Sclerosis

(2011) Patrice H. Lalive et al.   CNS DRUGS

Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients

(2011) N. Giannoukakis et al.   DIABETES CARE

Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: An ongoing story

(2011) Ana Caminero et al.   JOURNAL OF NEUROIMMUNOLOGY

Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse

(2011) Ana Longhini et al.   Journal of Neuroinflammation

Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis

(2010) Konstantin E. Balashov et al.   ANNALS OF NEUROLOGY

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis

(2010) R. A. Harry et al.   ANNALS OF THE RHEUMATIC DISEASES

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

(2010) J. M. Fletcher et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Antigen presentation in EAE: role of microglia, macrophages and dendritic cells

(2010) Beatriz Almolda   Frontiers in Bioscience-Landmark

An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis

(2010) N. Schwab et al.   JOURNAL OF IMMUNOLOGY

Plasmacytoid dendritic cells in multiple sclerosis: Chemokine and chemokine receptor modulation by interferon-beta

(2010) Latt Latt Aung et al.   JOURNAL OF NEUROIMMUNOLOGY

Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis

(2010) Halina Bartosik-Psujek et al.   Multiple Sclerosis Journal

Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis

(2009) A. Bayas et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Plasmacytoid Dendritic Cells in Multiple Sclerosis

(2009) Roberto Lande et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab

(2008) Maria del Pilar Martin   ARCHIVES OF NEUROLOGY

Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis

(2008) Adi Vaknin-Dembinsky et al.   JOURNAL OF NEUROIMMUNOLOGY

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

(2008) Benjamin M Segal et al.   LANCET NEUROLOGY

CTLA4Ig treatment in patients with multiple sclerosis: An open-label, phase 1 clinical trial

(2008) V. Viglietta et al.   NEUROLOGY